IKK-16 (also known as IKK Inhibitor VII; IKK-16; IKK16) is a novel, potent and selective IκBα kinase (IKK) inhibitor with potential anti-inflammatory activity.

Amlexanox (Amoxanox; AA-673; CHX-3673) is a potent and selective IKKε and TBK1 inhibitor which acts as anti-inflammatory antiallergic immunomodulator used to treat recurrent aphthous ulcers (canker sores), and (in Japan) several inflammatory conditions.

ACHP hydrochloride (also known as IKK-2 Inhibitor VIII), the hydrochloride salt of ACHP, is a novel, highly potent and selective IKK-β inhibitor with IC50 of 8.5 nM.

TBK1/IKKε-IN-1 is a novel, potent dual TBK1 and IKKε inhibitor with potential anticancer activity.

TPCA-1 (also known as TPCA1; GW-683965; GW683965) is novel, potent, and selective inhibitor of IKK-2 with potential anti-inflammatory activity.

BI605906 (BI-605906) is a novel and potent IKKβ inhibitor with anti-Inflammatory Effects.

GSK319347A is a novel, potent and dual inhibitor of TBK1 and IKKε with IC50s of 93 nM and 469 nM, respectively.

WS6 (WS6; WS 6) is a novel and potent small molecule modulator of β cell proliferation via modulation of Erb3 binding protein-1 (EBP1) and the IκB kinase pathway with important biological activity.

AZD3264 (AZD-3264; AZD 3264) is a novel and potent inhibitor of IKK2 (IkappaB Kinase/(IκB) with potential anti-inflammatory and anticancer activity.

WS-3 (WS3; WS 3) is a novel and potent small molecule modulatior of Erb3 binding protein-1 (EBP1) and the IκB (IkappaB) kinase with important biological activity.